.jpg)
2 hours ago
3
Article content
The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at VirtualInvestorConferences.com
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
MINNEAPOLIS, June 16, 2026 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, today announced that John Lai, Chief Executive Officer of PetVivo Holdings, Inc., will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on June 24th, 2026
Article content
Article content
Article content
DATE: June 24th
TIME: 12:00pm ET
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
Article content
Available for 1×1 meetings: June 24, 2026, through June 30, 2026. Schedule 1×1 Meetings here.
Article content
The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the opportunity to submit questions to management in real time. A replay of the webcast will be available following the conclusion of the conference.
Article content
It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.
Article content
Article content
Recent Company Highlights
PetVivo Holdings, Inc. is a veterinary medical technology company focused on improving the quality of life for companion animals through innovative medical device and other therapeutic solutions. Its flagship product, Spryng® with OsteoCushion® Technology, is a veterinarian-administered, intra-articular injection composed of biocompatible collagen-elastin microparticles designed to restore proper joint mechanics and assist in the management of lameness, osteoarthritis, and other joint-related conditions in dogs, cats, and horses. Unlike traditional therapies that primarily address symptoms, Spryng helps provide structural support within the joint and has demonstrated favorable clinical outcomes and safety profiles across multiple studies.
Article content
Article content
Recent highlights for PetVivo include continued expansion of Spryng commercialization efforts, growing clinical evidence supporting the product’s safety and efficacy, the advancement of international distribution initiatives, Health Canada recognition of Spryng as a veterinary medical device, the launch and development of PetVivo AI initiatives, and ongoing collaborations to expand the Company’s restorative technology and biomaterials portfolio for both animal and future human healthcare applications. The Company continues to leverage its proprietary technology platform, intellectual property portfolio, distributor relationships, and commercialization infrastructure to drive growth and expand market adoption.
Article content
About PetVivo Holdings, Inc.
Article content
PetVivo Holdings Inc. (OTCQX: PETV; OTCID: PETVW), in cooperation with its wholly owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI Inc., is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The Company’s strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics.
English (US)